Combination of ECG and Echocardiography for Identification of Arrhythmic Events in Early ARVC

JACC: Cardiovascular Imaging

Volumn 10, Issue 5, 2017, Pages 503-513

  Leren, Ida S ^a,b   Saberniak, Jørg ^a,b   Haland, Trine F ^a,b   Edvardsen, Thor ^a,b   Haugaa, Kristina H ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

arrhythmic risk; arrhythmogenic right ventricular cardiomyopathy; echocardiography; signal averaged ECG; ventricular arrhythmias

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ECHOCARDIOGRAPHY; ELECTRICAL PARAMETERS; ELECTROCARDIOGRAM; FAINTNESS; FEMALE; FOLLOW UP; HEART ARREST; HEART ARRHYTHMIA; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE BIOPSY; HEART RIGHT BUNDLE BRANCH BLOCK; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QRS INTERVAL; RISK ASSESSMENT; T WAVE INVERSION; TWO-DIMENSIONAL IMAGING; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; FEASIBILITY STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; RISK FACTOR;

ADULT; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; CROSS-SECTIONAL STUDIES; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 85008888459     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2016.06.011     Document Type: Article

References (28)

1. 1 Thiene, G., Nava, A., Corrado, D., Rossi, L., Pennelli, N., Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 318 (1988), 129–133.
2. 2 Saffitz, J.E., Arrhythmogenic cardiomyopathy and abnormalities of cell-to-cell coupling. Heart Rhythm 6:Suppl 8 (2009), S62–S65.
3. 3 Paul, M., Wichter, T., Fabritz, L., Waltenberger, J., Schulze-Bahr, E., Kirchhof, P., Arrhythmogenic right ventricular cardiomyopathy: an update on pathophysiology, genetics, diagnosis, and risk stratification. Herzschrittmacherther Elektrophysiol 23 (2012), 186–195.
4. 4 Groeneweg, J.A., Bhonsale, A., James, C.A., et al. Clinical presentation, long-term follow-up, and outcomes of 1001 arrhythmogenic right ventricular dysplasia/cardiomyopathy patients and family members. Circ Cardiovasc Genet 8 (2015), 437–446.
5. 5 Marcus, F.I., McKenna, W.J., Sherrill, D., et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation 121 (2010), 1533–1541.
6. 6 Saberniak, J., Hasselberg, N.E., Borgquist, R., et al. Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members. Eur J Heart Fail 16 (2014), 1337–1344.
7. 7 Sarvari, S.I., Haugaa, K.H., Anfinsen, O.G., et al. Right ventricular mechanical dispersion is related to malignant arrhythmias: a study of patients with arrhythmogenic right ventricular cardiomyopathy and subclinical right ventricular dysfunction. Eur Heart J 32 (2011), 1089–1096.
8. 8 Blomstrom-Lundqvist, C., Hirsch, I., Olsson, S.B., Edvardsson, N., Quantitative analysis of the signal-averaged QRS in patients with arrhythmogenic right ventricular dysplasia. Eur Heart J 9 (1988), 301–312.
9. 9 Nasir, K., Bomma, C., Tandri, H., et al. Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity: a need to broaden diagnostic criteria. Circulation 110 (2004), 1527–1534.
10. 10 Lang, R.M., Badano, L.P., Mor-Avi, V., et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16 (2015), 233–271.
11. 11 Edvardsen, T., Haugaa, K.H., Imaging assessment of ventricular mechanics. Heart 97 (2011), 1349–1356.
12. 12 Saberniak, J., Leren, I.S., Haland, T.F., et al. Comparison of patients with early-phase arrhythmogenic right ventricular cardiomyopathy and right ventricular outflow tract ventricular tachycardia. Eur Heart J Cardiovasc Imaging 18 (2017), 62–69.
13. 13 Haugaa, K.H., Amlie, J.P., Berge, K.E., Leren, T.P., Smiseth, O.A., Edvardsen, T., Transmural differences in myocardial contraction in long-QT syndrome: mechanical consequences of ion channel dysfunction. Circulation 122 (2010), 1355–1363.
14. 14 Haugaa, K.H., Smedsrud, M.K., Steen, T., et al. Mechanical dispersion assessed by myocardial strain in patients after myocardial infarction for risk prediction of ventricular arrhythmia. J Am Coll Cardiol Img 3 (2010), 247–256.
15. 15 Leren, I.S., Hasselberg, N.E., Saberniak, J., et al. Cardiac mechanical alterations and genotype specific differences in subjects with long QT syndrome. J Am Coll Cardiol Img 8 (2015), 501–510.
16. 16 Sen-Chowdhry, S., Syrris, P., Prasad, S.K., et al. Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. J Am Coll Cardiol 52 (2008), 2175–2187.
17. 17 Pinamonti, B., Dragos, A.M., Pyxaras, S.A., et al. Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry. Eur Heart J 32 (2011), 1105–1113.
18. 18 te Riele, A.S., James, C.A., Rastegar, N., et al. Yield of serial evaluation in at-risk family members of patients with ARVD/C. J Am Coll Cardiol 64 (2014), 293–301.
19. 19 Turrini, P., Angelini, A., Thiene, G., et al. Late potentials and ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol 83 (1999), 1214–1219.
20. 20 Liao, Y.C., Lin, Y.J., Chung, F.P., et al. Risk stratification of arrhythmogenic right ventricular cardiomyopathy based on signal averaged electrocardiograms. Int J Cardiol 174 (2014), 628–633.
21. 21 James, C.A., Bhonsale, A., Tichnell, C., et al. Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. J Am Coll Cardiol 62 (2013), 1290–1297.
22. 22 te Riele, A.S., James, C.A., Groeneweg, J.A., et al. Approach to family screening in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Eur Heart J 37 (2016), 755–763.
23. 23 Priori, S.G., Blomstrom-Lundqvist, C., Mazzanti, A., et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 36 (2015), 2793–2867.
24. 24 Corrado, D., Wichter, T., Link, M.S., et al. Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an International Task Force Consensus Statement. Circulation 132 (2015), 441–453.
25. 25 Mast, T.P., Teske, A.J., te Riele, A.S., et al. Prolonged electromechanical interval unmasks arrhythmogenic right ventricular dysplasia/cardiomyopathy in the subclinical Stage. J Cardiovasc Electrophysiol 27 (2016), 303–314.
26. 26 Kjaergaard, J., Hastrup Svendsen, J., Sogaard, P., et al. Advanced quantitative echocardiography in arrhythmogenic right ventricular cardiomyopathy. J Am Soc Echocardiogr 20 (2007), 27–35.
27. 27 Teske, A.J., Cox, M.G., te Riele, A.S., et al. Early detection of regional functional abnormalities in asymptomatic ARVD/C gene carriers. J Am Soc Echocardiogr 25 (2012), 997–1006.
28. 28 Haugaa, K.H., Bundgaard, H., Edvardsen, T., et al. Management of patients with arrhythmogenic right ventricular cardiomyopathy in the Nordic countries. Scand Cardiovasc J 49 (2015), 299–307.